HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/6/C1651    most recent 00518.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Bondesen, B. A. Articles by Pavlath, G. K. Search for Related Content PubMed PubMed Citation Articles by Bondesen, B. A. Articles by Pavlath, G. K.

MUSCLE CELL BIOLOGY AND CELL MOTILITY

The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms

¹Department of Pharmacology and ²Graduate Program in Biochemistry, Cell and Developmental Biology, Emory University, Atlanta, Georgia

Submitted 18 October 2005 ; accepted in final form 23 January 2006

Loss of muscle mass occurs with disease, injury, aging, and inactivity. Restoration of normal muscle mass depends on myofiber growth, the regulation of which is incompletely understood. Cyclooxygenase (COX)-2 is one of two isoforms of COX that catalyzes the synthesis of prostaglandins, paracrine hormones that regulate diverse physiological and pathophysiological processes. Previously, we demonstrated that the COX-2 pathway regulates early stages of myofiber growth during muscle regeneration. However, whether the COX-2 pathway plays a common role in adult myofiber growth or functions specifically during muscle regeneration is unknown. Therefore, we examined the role of COX-2 during myofiber growth following atrophy in mice. Muscle atrophy was induced by hindlimb suspension (HS) for 2 wk, followed by a reloading period, during which mice were treated with either the COX-2-selective inhibitor SC-236 (6 mg·kg^–1·day^–1) or vehicle. COX-2 protein was expressed and SC-236 attenuated myofiber growth during reloading in both soleus and plantaris muscles. Attenuated myofiber growth in the soleus was associated with both decreased myonuclear addition and decreased inflammation, whereas neither of these processes mediated the effects of SC-236 on plantaris growth. In addition, COX-2^–/– satellite cells exhibited impaired activation/proliferation in vitro, suggesting direct regulation of muscle cell activity by COX-2. Together, these data suggest that the COX-2 pathway plays a common regulatory role during various types of muscle growth via multiple mechanisms.

cyclooxygenase-2; prostaglandins; myonuclear number; satellite cells; inflammation

This article has been cited by other articles:

				A. Kadotani, Y. Tsuchiya, H. Hatakeyama, H. Katagiri, and M. Kanzaki Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C2C12 myotubes Am J Physiol Endocrinol Metab, December 1, 2009; 297(6): E1291 - E1303. [Abstract] [Full Text] [PDF]

				U. R. Mikkelsen, H. Langberg, I. C. Helmark, D. Skovgaard, L. L. Andersen, M. Kjaer, and A. L. Mackey Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise J Appl Physiol, November 1, 2009; 107(5): 1600 - 1611. [Abstract] [Full Text] [PDF]

				M. L Novak, W. Billich, S. M. Smith, K. B. Sukhija, T. J. McLoughlin, T. A. Hornberger, and T. J. Koh COX-2 inhibitor reduces skeletal muscle hypertrophy in mice Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1132 - R1139. [Abstract] [Full Text] [PDF]

				M Korotkova, S B. Helmers, I Loell, H Alexanderson, C Grundtman, C Dorph, I E Lundberg, and P-J Jakobsson Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis Ann Rheum Dis, November 1, 2008; 67(11): 1596 - 1602. [Abstract] [Full Text] [PDF]

				T. A. Trappe, C. C. Carroll, B. Jemiolo, S. W. Trappe, S. Dossing, M. Kjaer, and S. P. Magnusson Cyclooxygenase mRNA expression in human patellar tendon at rest and after exercise Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R192 - R199. [Abstract] [Full Text] [PDF]

				D. M. DiPasquale, M. Cheng, W. Billich, S. A. Huang, N. van Rooijen, T. A. Hornberger, and T. J. Koh Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1278 - C1285. [Abstract] [Full Text] [PDF]

				E. M. Weinheimer, B. Jemiolo, C. C. Carroll, M. P. Harber, J. M. Haus, N. A. Burd, J. K. LeMoine, S. W. Trappe, and T. A. Trappe Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: implications for COX-inhibiting drugs and protein synthesis Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2241 - R2248. [Abstract] [Full Text] [PDF]

				L. Arnold, A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis J. Exp. Med., May 14, 2007; 204(5): 1057 - 1069. [Abstract] [Full Text] [PDF]

				J. L. J. van der Velden, R. C. J. Langen, M. C. J. M. Kelders, J. Willems, E. F. M. Wouters, Y. M. W. Janssen-Heininger, and A. M. W. J. Schols Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1636 - C1644. [Abstract] [Full Text] [PDF]